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1. Introduction 
The membrane /.L chains from IgM molecules borne 
by normal polyclonal mouse B lymphocytes have an 
apparent molecular weight slightly larger than that of 
plasma cell secreted p chains as revealed by SDS- 
PAGE [ 1,2]. The same observation is made in com- 
paring unglycosylated pm and ps chains, synthesized 
in the presence of tunicamycin, which prevents the 
addition of asparagine-linked sugars [3,4]. We have 
shown that /.I~, but not ps chains, bind detergents, 
thus suggesting the presence of an hydrophobic region 
in the molecule [4]. We now show that these struc- 
tural differences are, at least in part, located towards 
the C-terminal end of the or chains. 
2. Materials and methods 
Membrane lymphocyte pm chains and plasma cell 
secreted ccs chains were prepared from biosyntheti- 
tally labeled purified mouse spleen lymphocytes, and 
from IgM polyclonal plasma cells, by immunoprecipi- 
tation followed by reduction, alkylation, and SDS- 
PAGE as detailed in [4-61. p Chains localized by 
radioautography were eluted from the gels by homog- 
enization in 0.05% SDS-O.05 M NH4HC0s buffer, 
lyophilized, and redissolved in 70% formic acid; they 
were desalted on Biogel P2 columns equilibrated in 
70% formic acid and cleaved in the same solvent 
Abbreviations: ws, secretory p chains; pm, membrane-bound 
CC chains; SD&sodium dodecyl sulphate;PAGE, polyacrylamide 
gelelectrophoresis;CNBr, cyanogen bromide;HPLC, high per- 
formance liquid chromatography; PTH, phenylthiohydantoin; 
amido acids are designated by the one-letter code 
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(1 ml) with 2.5 mg CNBr for 16 h at 4°C. The dried 
digests were run in 1 O-l 8% SDS--polyacrylamide 
gels, or in alkaline urea gels [7]. CNBr peptides were 
eluted from the gels and subjected to partial radioac- 
tive N-terminal sequence determination in a Beckman 
sequencer in the presence of 3 mg polybrene [8]. The 
same procedure was applied to CNBr peptide analysis 
of S-[2-14C]carboxamido-methylated p chain from 
myeloma protein TEPC 183 IgM. Carboxypeptidase A 
digestions were done in 0.05% SDS-O.05 M NH4HCOs 
buffer with 1 pg enzyme for 5-30 min at 37’C [9], 
and the identification of the released radioactive amino 
acids was carried out on an amino acid analyzer in the 
presence of a calibration mixture of cold amino acids. 
3. Results and discussion 
The reduced and alkylated chains obtained by 
immunoprecipitation of lysates of spleen small lym- 
phocytes labeled under the pulse-chase conditions 
described (fig.1) show, by SDS-PAGE analysis, two 
@ chain bands. The slower-moving one represents 
pm ‘chains since : 
(i) Its mobility in 1 -D and 2-D gels is identical to that 
of surface radioiodinated 12’Ij* chains [6]; 
(ii) It disappears electively after pronase treatment 
of intact cells [3,6]; 
(iii) It has an hydrophobic behaviour in the presence 
of detergents [4]. 
The kinetics of appearance of these two p chains, as 
well as the peptide composition of the faster-moving 
p chains, which is of the secretory type, are described 
in [6]. 
Biosynthetically labeled pm chains, localized by 
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radioautography (upper band in fig.lA), were eluted 
from preparative gels and compared to plasma cell 
~~ chains. CNBr digests of these 2 types of chains 
were analyzed by SDS-PAGE (fig.1 B) and by alkaline 
urea-PAGE (fig.2). 
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&.I. Autoradiographsof SDS-PAGE showing: (A) Reduced 
and alkylated anti-mouse Ig immunoprecipitate of a lysate of 
lymphocytes pulseLbeled for 2 h with [ “?S]C and various 
[aH]amino acids, then chased for 2 h. The chains migrating 
faster than the two n chains are probably 6 chains. L, light 
chains. (B) CNBr peptide patterns of biosynthe~ca~y labeled 
membrane (nm) and secreted &) chains on a 10-l 8% gra- 
dient SDS-PAGE. The numbered peptides were eluted and 
analyzed by partial N-terminal sequencing, followed by iden- 
tification and quantitation of the radioactive PTH residues by 
HPLC analysis in the presence of a cold PTH vibration mix- 
ture. Note that pm C-terminal fragment (507-?) has an appar- 
ent molecular size larger than r,C-terminalpeptide (507-576). 
The partial N-terminal sequence of the C-terminal peptide 
obtained from secretory myeloma MOPC 104E [lo] and 
TEPC 183 n chains is: 
507 
J, 
PEPGAPGFYFTHSILT... 
Secreted n chains were labeied with [?S]C, 13H]F, 13H]Y, 
[‘HI A, and [‘HJP, and nm chains, with [“‘S]C, [$H]F, 
[ ‘H]Y, [“HI1 and [“H]L..Edman degradation released the 
various radioactive PTH from both C-terminal fragments in the 
expected positions; i.e., P,,,, P,,,, A,,,, Psla, F,,,, Y 515, Prla 
for gs, and F,,,, Y,,,, F,,,, I,,, L,,, for pm. In the case of 
ps chains, the band moving faster than the C-terminal peptide 
also represents the same C-terminal peptide, starting at posi- 
tion 507, but in which the internal M residue located 8 resi- 
dues from the C-terminus has been cleaved. 
Fig.2. Autoradio~aphy of alkaline urea-PAGE of the CNBr 
digests of secreted (PL) and membrane (LY) n chains labeled 
with C or M. Slot I ,4, total CNBr digests of n, and pm chains, 
respectively ; slot 2 9, the CNBr C-terminal peptides of these 
respective chains isolated from SDS gels as shown in fig.1 B. 
Slots 5,6 correspond to the total CNBr digests of the 2 types 
of chains labeled with [a’S]M; ns C-terminal fragment is 
clearly labeled, but pm C-terminal peptide is not labeled. 
On SDS gels, 5 major CNBr peptides are visible. 
They were eluted, characterized by partial N-terminal 
radioactive sequencing, and compared with the N-ter- 
minal ammo acid sequences determined on comparable 
CNBr peptides obtained from mouse myeloma TEPC 
183 fi chains. Their loc~ization in the intact p chain 
sequence was established on the basis of the known 
primary structure of mouse myeloma MOPC 104 E 
~1 chain [ IO] (schematically numbered by their N-and 
C-terminal position in fig.lB). Two corresponding 
CNBr peptides from pm and fis chains display different 
mobilities: peptide 235-397, which we will not dis- 
cuss further, and the C-terminal peptide, which in the 
case of ~~ has an apparent molecular weight higher 
than that of ps Both fragments exhibit the same 
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N-terminal amino acid sequence and therefore span 
the end of the Cp4 domain (fig.1). 
When analyzed on alkaline urea gels (fig.2), the 
CNBr digest of ps showed a distinct rapidly migrating 
peptide (slot 1) which, after elution, was identified by 
partial N-terminal sequence as the C-terminal peptide. 
This peptide comigrates with the C-terminal peptide 
isolated from SDS gradient gel and rerun in urea gel 
(slot 2, flg.2). The digest of pm showed a different 
pattern, with a faster migrating peptide (slot 4), which 
is the C-terminal peptide, since it exhibits an identical 
mobility with the pm C-terminal peptide eluted from 
SDS gels (slot 3); thus, the pm C-terminal fragment 
exhibits a higher net negative charge than that derived 
from ps, which could correspond to the observation 
that, on 2-D gels, the precursors of pm chains are 
found to be more acidic than those of /J, chains [6]. 
Secreted p chains contain a M residue located 8 
positions from the C-terminus, which is partially 
cleaved by CNBr [lo]. Indeed, CNBr digest of [35S]M- 
labeled ps can be used to reveal the C-terminal pep- 
tide, both in SDS (not shown) or alkaline urea-PAGE 
(slot 5, fig.2). Conversely, the CNBr C-terminal pep- 
tide of [3sS]M-labeled pm is not detectable (slot 6, 
fig.2), indicating either that this peptide lacks the M 
residue, or that the C-terminal end of ~~ is cleaved 
by CNBr at a labile M residue. To explore this point, 
the C-terminal residue of this peptide was compared 
to that of intact y chains by carboxypeptidase treat- 
ment . 
Intact ps chains and ps C-terminal peptide sequen- 
tially released Y and C residues (fig.3), as expected 
from the known p,chain sequence [ 101; however, ~~ 
released Y but not C residue. In control experiments, 
the faster-moving /J chains extracted from gels as 
shown in fig.lA, which corresponds to lymphocytic 
ps [ 61, released Y and C like plasma cell pr This sug- 
gests that intact pm does not share the same C-termi- 
nal . . . C-Y sequence as ccs The same observation 
was made with unglycosylated clrn and p’s obtained 
under tunicamycin treatment (not shown). 
In contrast, the pm C-terminal CNBr peptide 
released neither C nor Y residues. This suggests that 
pm might contain a labile M residue close to the C-ter- 
minus, which was cleaved during CNBr digestion. 
These data conflict with reports suggesting that pm 
of mouse B lymphoma cells end, like cc,, with the same 
C-Y sequence [ 11-l 31. This might result from a con- 
fusion between pm and /.I~ chains and their precursors 
made by the same cell line, a mistake we made [3] 
1’5 
Time (min.) 
Fig.3. Carboxy-terminal tyrosine and cysteine released by 
carboxypeptidase A digestion from reduced and carboxamido- 
methyl-[s5S]C, [3H]Y labeled pm, gs, and from the corre- 
sponding C-terminal CNBr fragments: (Open symbols) Y 
release; (full symbols) C release; (a,.) pm; (or) P,; (d,m) ~~ 
C-terminal CNBr peptide; (O,+) pm C-terminal CNBr peptide. 
C was identified as carboxamidomethyl-[“SIC residue which 
elutes between D and S. The amount of radioactivity released 
by carboxypeptidase A ranged from 3-lo-times above the 
background radioactivity found in control experiments run in 
parallel without enzyme. The yields of Y were computed on 
the basis of 16 Y residues/molecule of n chains and 4 Y resi- 
dues/C-terminal peptides. Yields for C release were expressed 
on the basis of 14 C residues/r chain and 2 C residues/C-ter- 
minal fragment. 
before realizing that normal lymphocytes also synthe- 
size the 2 chain types [4,6]. In a human lymphoma 
cell line [ 141 /.I~ ended with a different C-terminal 
structure than that of ps. I-(~ synthesized by a mouse 
lymphoma cell line ends with the sequence . . . K-V-K 
(L. Hood, personal communication). This prompted 
us to examine if [jH] K-labeled firn isolated from nor- 
mal lymphocytes would release this residue under 
carboxypeptidase B treatment; this was found not to 
be the case (<2% of the expected release assuming 
that lysine was C-terminal). This observation is of 
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major interest since it suggests not only that pm dif- 
fer from ,us in their C-terminal regions, but that the 
genetic mech~isms responsible for this difference are 
not necessarily operating in an identical way in normal 
polyclonal lymphocytes and monoclonal B lymphoma 
cells. One possibility is that these mechanisms might 
be altered in some way in some B lymphoma cell lines. 
Alternatively, avariety of hydrophobic C-terminal 
tails of cl, might exist, and be expressed in polyclon~ 
normal B lymphocytes in contrast o monoclonal B 
lymphoma cells; however, this hypothesis appears less 
likely, in view of the quantitative kinetics of amino 
acids release shown in fig.3: here Y release from & 
chains, which all end by Y ,is closely comparable tothat 
observed from pm chains, strongly suggesting that 
most, if not all polyclonal pm chains have a tyrosine 
residue at, or very close to the C-terminus. 
Further studies have shown extensive peptide dif- 
ferences in the C-terminal half of y, and pm C-termi- 
nal CNBr fragments after proteolytic treatment, and 
will be reported elsewhere. 
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